You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Rifampin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for rifampin and what is the scope of freedom to operate?

Rifampin is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Chartwell Molecular, Epic Pharma Llc, Hikma, Lupin Pharms, Oxford Pharms, Avet Lifesciences, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, and Watson Pharms Teva, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Fifteen suppliers are listed for this compound.

Drug Prices for rifampin

See drug prices for rifampin

Recent Clinical Trials for rifampin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institut PasteurPhase 3
Centre Hospitalier Universitaire de CaenPhase 3
Ministry of Health, FrancePhase 3

See all rifampin clinical trials

Pharmacology for rifampin

US Patents and Regulatory Information for rifampin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc RIFAMPIN rifampin CAPSULE;ORAL 064150-001 May 28, 1997 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Molecular RIFAMPIN rifampin CAPSULE;ORAL 065390-001 Mar 28, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us RIFADIN rifampin CAPSULE;ORAL 050420-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc RIFAMPIN rifampin CAPSULE;ORAL 064150-002 Jan 2, 1998 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.